Latest Breaking News On - Newell rogers - Page 1 : comparemela.com

GLOBAL CANCER TECHNOLOGY RECEIVES INITIAL PRE-CLINICAL RESULTS OF GCT-007 IN PSORIASIS

GLOBAL CANCER TECHNOLOGY RECEIVES INITIAL PRE-CLINICAL RESULTS OF GCT-007 IN PSORIASIS
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesJohn clarkM karen newell rogersJean christopher chamcheuEinpresswire global cancer technology incSchool of basic pharmaceutical toxicological sciencesUniversity of louisiana at monroeTexasam universityScientific consultant for global cancer technologyGlobal cancer technologyGlobal cancer technology psoriasisJean christopherCancer technologyNewell rogersChief scientific consultantBasic pharmaceutical

Global Cancer Technology Licenses Biomarker Technology from Baylor Scott & White Research Institute to Support Research Efforts Towards Treatment for Glioblastoma

Global Cancer Technology Licenses Biomarker Technology from Baylor Scott & White Research Institute to Support Research Efforts Towards Treatment for Glioblastoma
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesM karen newell rogersAmyc oliverNewell rogersBaylor scott whiteErxi wuPrnewswire global cancer technologyBaylor scott white research instituteGlobal cancer technologyOncology research centerCancer technologyBaylor scottWhite research instituteChief scientific consultantGlobal cancerTexas immuno oncology biorepository

BioSpace Movers & Shakers, June 4

Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

Wills eye hospitalUnited statesM karen newell rogersMyers squibbDenise straussMarc semigranDavidc hanleyEric castaldiJen hongMeagher flomMarc massiotNewell rogersRobin knifsendTheodore reissJeff cruikshankEvelo biosciences

BioSpace Movers & Shakers, June 4

Published: Jun 03, 2021 By Alex Keown 180 Life Sciences Russell T. Ray and Teresa DeLuca were appointed to the board of directors of 180 Life Sciences. Ray was formerly Managing Director and co-Head of Global Health Care at Credit Suisse First Boston Corporation. More recently, Ray was a Partner and Senior Advisor to HLM Venture Partners, a health care-focused venture capital firm. He currently serves on the board of directors of Merrimack Pharmaceuticals, Inc. DeLuca comes to 180 Life Sciences as both a public independent board director and former senior executive Chief Medical Officer. Her most recent role was at Columbia University as Managing Director of NY Life Science Venture Fund.

Wills eye hospitalUnited statesM karen newell rogersMyers squibbDenise straussMarc semigranDavidc hanleyEric castaldiJen hongMeagher flomMarc massiotNewell rogersRobin knifsendTheodore reissJeff cruikshankEvelo biosciences

Global Cancer Technology Appoints Chief Scientific Consultant and Advisor as Company Expands to Include New Technology and Treatments for Brain Cancer, SEC filings

/PRNewswire/ Global Cancer Technology the cancer research company using invisible dots to solve visible problems in healthcare today announced the.

United statesColorado springsM karen newell rogersAmyc oliverNewell rogersJohnp clarkResearch professorHazards centerBarrow neurological instituteGlobal cancer technologyLeukemia society of americaUniversity of california san diegoSenior research professorMcgill universityTrauma healthUniversity of texas at austin